SEC Form 4 · accession 0001773751-26-000110
Hims & Hers Health, Inc. · HIMS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher D Payne
Director
Period of report
Jun 11, 2026
Accepted (ET)
Jun 15, 2026 · 5:13 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001773751
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | Jun 11, 2026 | M | 3,656 | — | A | 23,631 | D | |
| Class A Common StockF2 | Jun 15, 2026 | M | 10,040 | — | A | 33,671 | D | |
| Class A Common StockF3 | Jun 15, 2026 | M | 647 | — | A | 34,318 | D | |
| Class A Common Stock | holding | — | — | — | 110,000 | I | Held by The Payne Family Trust dtd 09/17/2020 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1 | — | Jun 11, 2026 | M | 3,656 | D | — | — | Class A Common Stock | 3,656 | 0 | D |
| Restricted Stock UnitF4,F2 | — | Jun 15, 2026 | M | 10,040 | D | — | — | Class A Common Stock | 10,040 | 10,040 | D |
| Restricted Stock UnitF4,F3 | — | Jun 15, 2026 | M | 647 | D | Jun 15, 2026 | — | Class A Common Stock | 647 | 0 | D |
Explanation of responses
- F1The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026.
- F2The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 3-year period, with : (i) 1/3 of the RSUs vesting on June 15, 2025, (ii) 1/3 of the RSUs vesting on June 15, 2026, and (iii) 1/3 of the RSUs vesting on May 15, 2027.
- F3The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer and committee membership fees for the first quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $14,875 by the grant price of $22.98. The RSUs will vest in full on the Company's next quarterly vesting date.
- F4The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.